Agile Could Reach $10/Share After Twirla Approval [Seeking Alpha]
Agile Therapeutics, Inc. (AGRX)
Last agile therapeutics, inc. earnings: 5/2 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.agiletherapeutics.com/investor-relations
Company Research
Source: Seeking Alpha
Agile Therapeutics (NASDAQ: AGRX has received approval FDA here So, what's next for the company and its stock price? The future is bright. Twirla's Commercial Prospects Twirla is a once-a-week transdermal treatment with a combined hormonal approach that delivers a 30 mcg daily dose of ethinyl estradiol (a type of estrogen) and a 120 mcg daily dose of levonorgestrel (a well-known progestin). The patch can be worn on the abdomen, buttock, or upper torso. INDICATION AND USAGE TWIRLA is indicated as a method of contraception for use in women of reproductive potential with a BMI 25 to 30 kg/m This label is better than expected, given the discussion at the October BRUDAC meeting and that AGRX is well-positioned to build a sales force to start marketing the patch to prescribers. While Twirla is contraindicated in 30 BMI women, the label merely directs prescribers to "consider Twirla's reduced effectiveness" in women with a 25-30 BMI, giving clinicians wide latitude to offer their patients
Show less
Read more
Impact Snapshot
Event Time:
AGRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGRX alerts
High impacting Agile Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics